对抗MAG神经病变的患者进行短期随访,这些患者接受了班达穆斯丁加上利图西马布联合治疗
1Service de Neurologie clinique, Hôpital Saint-Vincent de Paul, Lille, France.
Revue neurologique
|December 22, 2025
概括
班达穆斯丁-利图西马布 (BR) 组合疗法显示出治疗抗髓关联葡萄糖蛋白 (抗MAG) 神经病变的潜力,改善了临床和电生理学结果. 建议使用神经病障损伤得分 (NIS) 等敏感尺度进行进一步的研究.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
背景情况:
- 抗髓相关葡萄糖蛋白 (anti-MAG) IgM抗体会导致致残性脱髓神经病变.
- 传统的治疗包括单独使用Rituximab.
研究的目的:
- 评估本达穆斯丁-利图西马布 (BR) 联合治疗抗MAG神经病变的临床和电生理疗效.
主要方法:
- 对11名接受BR联合治疗的抗MAG神经病变患者的回顾性分析.
- 在治疗前和治疗后收集的临床分数和电生理学数据 (治疗后平均8.40个月).
主要成果:
- 在整体神经病障碍局限性尺度 (ONLS) 上有54%的改善,在周围神经病障碍 (PND) 评分上有45%的改善,没有统计学意义.
- 5/6名患者在神经病变障碍评分 (NIS) 中有所改善 (P=0.021),并注意到感官改善.
- 62%的患者符合电生理学改善标准;较高的基线PND得分与较低的电诊断改善相关.
结论:
- 在抗MAG患者中,BR疗法似乎改善了临床和电生理学结果.
- 像NIS这样的敏感尺度对于监测治疗反应至关重要.
- 需要进行更大规模的前性研究来证实BR疗法的疗效.
相关概念视频
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
